Stevenson J C, Proudler A J, Walton C, Godsland I F
Wynn Institute for Metabolic Research, London, U.K.
Int J Fertil Menopausal Stud. 1994;39 Suppl 1:50-5.
Elevated insulin concentrations are frequently found in both men and women with coronary heart disease (CHD), and are likely to be due to insulin resistance. Hyperinsulinaemia may increase CHD risk by directly promoting atherogenesis, and insulin propeptides may also be important in this respect. However, increased insulin concentrations may adversely affect several other CHD risk factors, and it has been postulated that insulin resistance is a pivotal metabolic disturbance in a constellation of CHD risk factors. There is an association between hyperinsulinaemia and hypertension, although it is not known if this association is direct. Increased insulin concentrations are also associated with high triglycerides, low HDL or HDL2 concentrations, and increased small dense LDL. Obesity is also associated with insulin resistance, and it is the central or android body fat distribution which correlates with these metabolic disturbances. All these associated factors constitute a distinct syndrome--the insulin resistance syndrome--which is a frequent finding in patients with CHD, including microvascular angina. It is possible that the adverse associations of insulin resistance and dyslipidaemia are mediated through increased nonesterified fatty acid flux. Increased insulin levels are also associated with increases in the anti-fibrinolytic factor, plasminogen activator inhibitor-I (PAI-I). Whilst increased insulin levels are typically associated with insulin resistance, reduced hepatic insulin uptake may also be important. We now have techniques which can quantitate insulin secretion, hepatic uptake and release, elimination, and resistance. The menopause has appreciable effect on insulin and glucose metabolism. Estrogen and progesterone augment pancreatic insulin secretion, but the former reduces insulin resistance whilst the latter increases it.(ABSTRACT TRUNCATED AT 250 WORDS)
冠心病(CHD)患者中,无论男性还是女性,胰岛素浓度升高都很常见,这可能是胰岛素抵抗所致。高胰岛素血症可能通过直接促进动脉粥样硬化增加冠心病风险,胰岛素原肽在这方面可能也很重要。然而,胰岛素浓度升高可能对其他几种冠心病危险因素产生不利影响,据推测胰岛素抵抗是一系列冠心病危险因素中关键的代谢紊乱。高胰岛素血症与高血压之间存在关联,尽管尚不清楚这种关联是否直接。胰岛素浓度升高还与高甘油三酯、低高密度脂蛋白(HDL)或HDL2浓度以及小而密低密度脂蛋白(LDL)增加有关。肥胖也与胰岛素抵抗有关,与这些代谢紊乱相关的是中心性或男性型体脂分布。所有这些相关因素构成了一种独特的综合征——胰岛素抵抗综合征,这在冠心病患者中很常见,包括微血管性心绞痛患者。胰岛素抵抗和血脂异常的不良关联可能是通过非酯化脂肪酸通量增加介导的。胰岛素水平升高还与抗纤溶因子纤溶酶原激活物抑制剂 -I(PAI-I)增加有关。虽然胰岛素水平升高通常与胰岛素抵抗有关,但肝脏胰岛素摄取减少可能也很重要。我们现在有技术可以定量胰岛素分泌、肝脏摄取和释放、清除以及抵抗。绝经对胰岛素和葡萄糖代谢有显著影响。雌激素和孕激素可增强胰腺胰岛素分泌,但前者降低胰岛素抵抗,而后者增加胰岛素抵抗。(摘要截短至250字)